These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 15671122)
1. Cannabis antagonists: a new era of social psychopharmacology? Nutt D J Psychopharmacol; 2005 Jan; 19(1):3-4. PubMed ID: 15671122 [No Abstract] [Full Text] [Related]
2. New options for drug treatment of obesity in patients with Type 2 diabetes. Kennedy RL; Khoo EY Diabet Med; 2005 Sep; 22 Suppl 4():23-6. PubMed ID: 16109016 [No Abstract] [Full Text] [Related]
3. New diet drug stirs high hopes. But can the pill, rimonabant, liver up to large expectations? Heart Advis; 2005 Feb; 8(2):3. PubMed ID: 15806687 [No Abstract] [Full Text] [Related]
4. Pharmacotherapy for obesity--promise and uncertainty. Yanovski SZ N Engl J Med; 2005 Nov; 353(20):2187-9. PubMed ID: 16291989 [No Abstract] [Full Text] [Related]
5. Cannabinoid antagonists: a treatment in search of an illness. D'Souza DC; Kosten TR Arch Gen Psychiatry; 2001 Apr; 58(4):330-1. PubMed ID: 11296092 [No Abstract] [Full Text] [Related]
6. Weeding out new drugs. Ewan S Drug Discov Today; 2005 Oct; 10(20):1336-7. PubMed ID: 16253865 [No Abstract] [Full Text] [Related]
7. Efficacy and safety of the weight-loss drug rimonabant. Blüher M Lancet; 2008 Feb; 371(9612):555-6; author reply 556-7. PubMed ID: 18280321 [No Abstract] [Full Text] [Related]
8. Metabolic risk factors, drugs, and obesity. Padwal R; Majumdar S N Engl J Med; 2006 Mar; 354(9):974-5; author reply. PubMed ID: 16510755 [No Abstract] [Full Text] [Related]
9. Endogenous cannabinoids: a new target in the treatment of obesity. Kirkham TC Am J Physiol Regul Integr Comp Physiol; 2003 Feb; 284(2):R343-4. PubMed ID: 12529283 [No Abstract] [Full Text] [Related]
10. Multiple impacts of rimonabant on cardiometabolic risk and safety addressed at ESC congress, Vienna. Cardiovasc J Afr; 2007; 18(5):336-7. PubMed ID: 17985035 [No Abstract] [Full Text] [Related]
18. [The endocannabinoid system and treatment of obesity]. Aronsen L Tidsskr Nor Laegeforen; 2008 Feb; 128(5):570-1. PubMed ID: 18311201 [TBL] [Abstract][Full Text] [Related]
19. Experimental drugs take aim at obesity. Vastag B JAMA; 2003 Apr; 289(14):1763-4. PubMed ID: 12684341 [No Abstract] [Full Text] [Related]
20. [2008: the end of rimonabant's story]. Paris M Ann Pharm Fr; 2009 May; 67(3):167-8. PubMed ID: 19446664 [No Abstract] [Full Text] [Related] [Next] [New Search]